Identification of proteins that interact with tank binding kinase 1 and testing for mutations associated with glaucoma

Current Eye Research

Volumn 38, Issue 2, 2013, Pages 310-315

  Seo, Seongjin ^a   Solivan Timpe, Frances ^a   Roos, Ben R ^a   Robin, Alan L ^b,c   Stone, Edwin M ^a,d   Kwon, Young H ^a   Alward, Wallace L M ^a   Fingert, John H ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UPR   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Glaucoma; Tandem affinity purification; TKB1

Indexed keywords

BINDING PROTEIN; TANK BINDING KINASE 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOPHAGY; CONTROLLED CLINICAL TRIAL; DISEASE ASSOCIATION; DNA SEQUENCE; GENE MUTATION; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN CELL; LOW TENSION GLAUCOMA; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; GENE DOSAGE; GENE DUPLICATION; HEK293 CELLS; HUMANS; LOW TENSION GLAUCOMA; POINT MUTATION; PROTEIN-SERINE-THREONINE KINASES; TNF RECEPTOR-ASSOCIATED FACTOR 2;

EID: 84873926194     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2012.754047     Document Type: Article

References (33)

1. Tielsch JM. Blindness and visual impairment in an american urban population. Arch Ophthalmol 1990;108:286-290.
2. Kahn HA, Milton RC. Revised Framingham eye study prevalence of glaucoma and diabetic retinopathy. Am J Epidemiol 1980;111:769-776.
3. Fingert JH, Heon E, Liebmann JM, Yamamoto T, Craig JE, Rait J, et al. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet 1999;8:899-905.
4. Fingert JH, Stone EM, Sheffield VC, Alward WL. Myocilin glaucoma. Surv Ophthalmol 2002;47:547-561.
5. Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002;295:1077-1079.
6. Fingert JH. Primary open-angle glaucoma genes. Eye (Lond) 2011;25:587-595.
7. Monemi S, Spaeth G, Dasilva A, Popinchalk S, Ilitchev E, Liebmann J, et al. Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum Mol Genet 2005;14:725-733.
8. Hewitt AW, Dimasi DP, Mackey DA, Craig JE. A glaucoma case-control study of the WDR36 gene D658G sequence variant. Am J Ophthalmol 2006;142:324-325.
9. Fingert JH, Alward WL, Kwon YH, Shankar SP, Andorf JL, Mackey DA, et al. No association between variations in the WDR36 gene and primary open-angle glaucoma. Arch Ophthalmol 2007;125:434-436.
10. Hauser MA, Allingham RR, Linkroum K, Wang J, LaRocque-Abramson K, Figueiredo D, et al. Distribution of WDR36 DNA sequence variants in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2006;47:2542-2546.
11. Pasutto F, Matsumoto T, Mardin CY, Sticht H, Brandstatter JH, Michels-Rautenstrauss K, et al. Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucoma. Am J Hum Genet 2009;85:447-456.
12. Liu Y, Liu W, Crooks K, Schmidt S, Allingham RR, Hauser MA. No evidence of association of heterozygous NTF4 mutations in patients with primary open-angle glaucoma. Am J Hum Genet 2010;86:498-499; author reply 500.
13. Pasutto F, Keller KE, Weisschuh N, Sticht H, Samples JR, Yang YF, et al. Variants in ASB10 are associated with openangle glaucoma. Hum Mol Genet 2012;21:1336-1349.
14. Fingert JH, Roos BR, Solivan-Timpe F, Miller KA, Oetting TA, Wang K, et al. Analysis of ASB10 variants in open angle glaucoma. Hum Mol Genet 2012;21:4543-8.
15. Meguro A, Inoko H, Ota M, Mizuki N, Bahram S. Genomewide association study of normal tension glaucoma: common variants in SRBD1 and ELOVL5 contribute to disease susceptibility. Ophthalmology 2010;117:1331-1338. e5.
16. Shibuya E, Meguro A, Ota M, Kashiwagi K, Mabuchi F, Iijima H, et al. Association of Toll-like receptor 4 gene polymorphisms with normal tension glaucoma. Invest Ophthalmol Vis Sci 2008;49:4453-4457.
17. Burdon KP, Crawford A, Casson RJ, Hewitt AW, Landers J, Danoy P, et al. Glaucoma risk alleles at CDKN2B-AS1 are associated with lower intraocular pressure, normal-tension glaucoma, and advanced glaucoma. Ophthalmology 2012;119:1539-1545.
18. Fingert JH, Robin AL, Stone JL, Roos BR, Davis LK, Scheetz TE, et al. Copy number variations on chromosome 12q14 in patients with normal tension glaucoma. Hum Mol Genet 2011;20:2482-2494.
19. Kawase K, Allingham RR, Meguro A, Mizuki N, Roos B, Solivan-Timpe FM, et al. Confirmation of TBK1 duplication in normal tension glaucoma. Exp Eye Res 2012;96:178-180.
20. Yang Z, Klionsky DJ. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 2010;22:124-131.
21. Weidberg H, Elazar Z. TBK1 mediates crosstalk between the innate immune response and autophagy. Sci Signal 2011;4:pe39.
22. Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, Brady NR, et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 2011;333:228-233.
23. Seo S, Zhang Q, Bugge K, Breslow DK, Searby CC, Nachury MV, et al. A novel protein LZTFL1 regulates ciliary trafficking of the BBSome and Smoothened. PLoS Genet 2011;7:e1002358.
24. Henikoff S, Henikoff JG. Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci USA 1992;89:10915-10919.
25. Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 2003;31:3812-3814.
26. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 2002;30:3894-3900.
27. Exome Variant Server. NHLBI Exome Sequencing Project (ESP). Available from: http://evs.gs.washington.edu/EVS/[last accessed Mar 2012].
28. Piras A, Gianetto D, Conte D, Bosone A, Vercelli A. Activation of autophagy in a rat model of retinal ischemia following high intraocular pressure. PLoS One 2011;6:e22514.
29. Park HY, Kim JH, Park CK. Activation of autophagy induces retinal ganglion cell death in a chronic hypertensive glaucoma model. Cell Death Dis 2012;3:e290.
30. Cheng G, Baltimore D. TANK, a co-inducer with TRAF2 of TNF-and CD 40L-mediated NF-kappaB activation. Genes Dev 1996;10:963-973.
31. Ryzhakov G, Randow F. SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J 2007;26:3180-3190.
32. Fujita F, Taniguchi Y, Kato T, Narita Y, Furuya A, Ogawa T, et al. Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling. Mol Cell Biol 2003;23:7780-7793.
33. Pomerantz JL, Baltimore D. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J 1999;18:6694-6704.